Affymetrix teams with Bio-Genesys to offer genetic testing for livestock

California-based Affymetrix ($AFFY) and Bio-Genesys Diagnostics of the U.K. announced on January 12 that they have formed a partnership to offer genotyping services to professional farmers. Bio-Genesys currently offers genetic testing aimed at improving the breeding of cattle, goats, sheep and other animals. The two companies co-developed a breeding array that's now sold in Europe, according to the press release announcing the new deal. Under the agreement, all of Bio-Genesys' services will be run on Affymetrix technology. Financial details were not disclosed. Release

Suggested Articles

Pfizer spinoff Zoetis met Q2 expectations and brightened its full-year forecast, but it's looking to M&A to drive further growth.

Fresenius’ new CEO has pulled off a dealmaking double play, committing more than $5.4 billion to expand its reach in both sterile generics and in biosimilars.

Bayer’s pharma products have been growing lickety-split, and its 2016 numbers show just how—and how much. But with the big Monsanto merger top of mind at Bayer…